INNPF
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
36.56M
KKPCF
Price
$28.09
Change
+$1.18 (+4.38%)
Updated
Apr 28 closing price
Capitalization
983.91M
Interact to see
Advertisement

INNPF vs KKPCF

Header iconINNPF vs KKPCF Comparison
Open Charts INNPF vs KKPCFBanner chart's image
Innocan Pharma
Price$0.15
Change-$0.00 (-0.00%)
Volume$7.44K
Capitalization36.56M
Kaken Pharmaceutical
Price$28.09
Change+$1.18 (+4.38%)
Volume$200
Capitalization983.91M
INNPF vs KKPCF Comparison Chart in %
Loading...
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INNPF vs. KKPCF commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INNPF is a Buy and KKPCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (INNPF: $20.05 vs. KKPCF: $28.09)
Brand notoriety: INNPF and KKPCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INNPF: 170% vs. KKPCF: 100%
Market capitalization -- INNPF: $36.56M vs. KKPCF: $983.91M
INNPF [@Pharmaceuticals: Generic] is valued at $36.56M. KKPCF’s [@Pharmaceuticals: Generic] market capitalization is $983.91M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INNPF’s FA Score shows that 1 FA rating(s) are green whileKKPCF’s FA Score has 1 green FA rating(s).

  • INNPF’s FA Score: 1 green, 4 red.
  • KKPCF’s FA Score: 1 green, 4 red.
According to our system of comparison, INNPF is a better buy in the long-term than KKPCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INNPF’s TA Score shows that 7 TA indicator(s) are bullish.

  • INNPF’s TA Score: 7 bullish, 2 bearish.

Price Growth

INNPF (@Pharmaceuticals: Generic) experienced а +5.53% price change this week, while KKPCF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.87%. For the same industry, the average monthly price growth was +11.08%, and the average quarterly price growth was +76.49%.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.87% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KKPCF($984M) has a higher market cap than INNPF($36.6M). INNPF YTD gains are higher at: 6.759 vs. KKPCF (4.899). KKPCF has higher annual earnings (EBITDA): 26B vs. INNPF (219M). KKPCF has more cash in the bank: 84B vs. INNPF (5.01M). INNPF has less debt than KKPCF: INNPF (1.44B) vs KKPCF (3.85B). KKPCF has higher revenues than INNPF: KKPCF (87.2B) vs INNPF (727M).
INNPFKKPCFINNPF / KKPCF
Capitalization36.6M984M4%
EBITDA219M26B1%
Gain YTD6.7594.899138%
P/E RatioN/A11.30-
Revenue727M87.2B1%
Total Cash5.01M84B0%
Total Debt1.44B3.85B37%
TECHNICAL ANALYSIS
Technical Analysis
INNPFKKPCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
56%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
11%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
11%
Advances
ODDS (%)
Bullish Trend 5 days ago
48%
N/A
Declines
ODDS (%)
Bearish Trend 21 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
51%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GVCAX11.68N/A
N/A
Gabelli Value 25 AAA
LBRIX31.40N/A
N/A
ClearBridge Dividend Strategy FI
PGKCX27.04N/A
N/A
PGIM Jennison Technology C
PGWTX39.13N/A
N/A
Putnam Focused Equity R6
HRSGX12.25-0.13
-1.05%
Harbor Small Cap Growth Admin

INNPF and

Correlation & Price change

A.I.dvisor tells us that INNPF and HYEX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNPF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
-0.55%
HYEX - INNPF
20%
Poorly correlated
+10.67%
APNHF - INNPF
20%
Poorly correlated
N/A
BIOVF - INNPF
20%
Poorly correlated
N/A
KKPCF - INNPF
6%
Poorly correlated
N/A
VEXTF - INNPF
6%
Poorly correlated
-2.57%
More

KKPCF and

Correlation & Price change

A.I.dvisor tells us that KKPCF and OVATF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KKPCF and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KKPCF
1D Price
Change %
KKPCF100%
N/A
OVATF - KKPCF
24%
Poorly correlated
N/A
INNPF - KKPCF
6%
Poorly correlated
-0.55%
LOVFF - KKPCF
6%
Poorly correlated
-2.21%
GEDSF - KKPCF
3%
Poorly correlated
N/A
KAYS - KKPCF
2%
Poorly correlated
-8.01%
More